These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3007042

  • 1. Current chemotherapy of small cell lung cancer.
    Livingston RB.
    Chest; 1986 Apr; 89(4 Suppl):258S-263S. PubMed ID: 3007042
    [Abstract] [Full Text] [Related]

  • 2. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.
    Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Donnelly EJ, Raub WA.
    Am J Clin Oncol; 1994 Dec; 17(6):527-37. PubMed ID: 7977175
    [Abstract] [Full Text] [Related]

  • 3. Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
    Viallet J, Ihde DC.
    J Clin Oncol; 1989 Aug; 7(8):985-7. PubMed ID: 2547029
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J, Whitacre M, Van Echo DA, Wiernik PH.
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T, Hiraki S, Ueoka H, Kawahara S, Numata T, Nishii K, Yonei T, Yamashta H, Kiura K, Kozuka A.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
    Daniels JR, Chak LY, Sikic BI, Lockbaum P, Kohler M, Carter SK, Reynolds R, Bohnen R, Gandara D, Yu J.
    J Clin Oncol; 1984 Nov; 2(11):1192-9. PubMed ID: 6092554
    [Abstract] [Full Text] [Related]

  • 15. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N, Shah A, Wilson K, Goldie J, Voss N, Fryer C, Klimo P, Coy P, Hadzic E, Gudauskas G.
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [Abstract] [Full Text] [Related]

  • 16. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.
    Eagan RT, Frytak S, Richardson RL, Creagan ET, Therneau TM, Coles DT, Jett JR.
    J Clin Oncol; 1988 Jan; 6(1):5-8. PubMed ID: 2826714
    [Abstract] [Full Text] [Related]

  • 17. Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study.
    Wampler GL, Heim WJ, Ellison NM, Ahlgren JD, Fryer JG.
    J Clin Oncol; 1991 Aug; 9(8):1438-45. PubMed ID: 1649265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.